Skip to content

Immediate Effects of Self-myofascial Release on Latent Trigger Point Sensitivity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02609412
Enrollment
48
Registered
2015-11-20
Start date
2015-05-31
Completion date
2016-05-31
Last updated
2016-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger Points

Brief summary

Latent myofascial trigger points (LMTRP) which impair neuromuscular performance occur in both, patients and asymptomatic subjects. As evidence suggests that LMTRP can transform into active trigger points, therapy seems warranted. Besides other modalities, self-massage using foam rollers (self-myofascial release) has been applied as a treatment. However, there is no data on the efficacy of this method concerning LMTRP. Thus, the present study aims to evaluate the effects of different forms of self-myofascial release on LMTRP pain. Healthy patients with LMTRP in the calf are randomly allocated to one of three groups: 1) 90s static compression of the most sensitive LMTRP by means of the foam roll, 2) dynamic self-myofascial release rolling back and forth on the calf muscles for 90s using a foam roller, 3) placebo laser acupuncture of the most sensitive LMTRP. All subjects participate in a familiarization session with the foam roller one week prior to treatments. As an outcome, pressure pain threshold is assessed with an algometer. The investigators hypothesize, that static compression can reduce pressure pain of LMTRP more effective than dynamic self-myofascial release. The investigators further expect that placebo treatment will be the least effective method.

Interventions

OTHERStatic compression of LMTRP

Static compression of most sensitive Triggerpoint with a foam roller (Blackroll Inc., Germany).

OTHERDynamic self-myofascial release of calf

Dynamic self-massage of the calf with a foam roller (Blackroll Inc., Germany).

DEVICEPlacebo laser acupuncture of LMTRP

Used device: Laserneedle System (Laserneedle Systems GmbH, Glienicke/Nordbahn, Germany). Electrodes positioned on skin but device remains switched off.

Sponsors

Goethe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* at least one diagnosed latent myofascial trigger point in the calf * age 18 to 65 years * written informed consent

Exclusion criteria

* active myofascial trigger point in the calf * regular intake of drugs or within past 48 hours * severe psychiatric, neurological, orthopaedic, cardiovascular or endocrine diseases * pregnancy or nursing period * any condition that negatively influences current quality of life

Design outcomes

Primary

MeasureTime frame
Change in pressure pain threshold [kg/cm²] assessed by pressure algometerBaseline (M1) - 3 minutes (M2)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026